Atlas Trials

Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery

Clinical trial NCT00524069 · WITHDRAWN

Trial details

NCT number
NCT00524069
Sponsor
Roswell Park Cancer Institute
Status
WITHDRAWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2007-01-01
Primary completion
2007-11-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.